Welcome to the e-CCO Library!

P847: Perceptions of faecal microbiota transplantation in a paediatric ulcerative colitis population (PediFETCh Trial)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Popov*1, E. Hartung2,3, L. Hill2,4, U. Chauhan5, N. Pai2

Created: Friday, 22 February 2019, 9:41 AM
P848 A novel grape-derived prebiotic selectively enhances abundance and metabolic activity of butyrate producing bacteria in faecal samples of inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Oliver1, S. Ramió-Pujol2, J. Amoedo3, M. Malagón3, M. Serrano4, A. Bahí5, A. Lluansí5, D. Busquets6, T. Leyanira6, M. Serra-Pagès7, X. Aldeguer6, G.G. Jesús8

Created: Thursday, 30 January 2020, 10:12 AM
P848: FXR -1G>T (rs56163822) predicts deleterious outcomes in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Wilson1*, W. Teft2, A. Al-Mousa2, R. Kim3

Created: Thursday, 21 February 2019, 9:14 AM
P848: Latent tuberculosis and active tuberculosis infection in patients with inflammatory bowel disease treating by biological agents: an experience of a medical centre in Taiwan
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H-C. Lai*1, K-S. Cheng2,3, C-H. Chang2, C-L. Feng2, T-W. Chen3,4, J-W. Chou2,3,5

Created: Friday, 22 February 2019, 9:41 AM
P848: Risk of Orthorexia Nervosa in Patients with Inflammatory Bowel Disease: A Link with Eating Disorders?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Di Giorgio, F.M.(1)*;Modica, S.P.(2);Ciminnisi, S.(2);Saladino, M.(2);Muscarella, S.(2);Melatti, P.(2);Brinch, D.(2);Petta, S.(2);Cappello, M.(2);
Created: Friday, 14 July 2023, 11:12 AM
P849 Analysis of rectal swabs for microbiome sampling in a cohort of IBD patients during disease exacerbation. POLIBD survey results
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Filip1, J. Gruszecka2

Created: Thursday, 30 January 2020, 10:12 AM
P849: Exposure to metals and minerals in hair samples of patients with preclinical inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rodríguez-Lago, I.(1)*;Rodríguez, A.(1);Elorza, A.(1);Sampedro, B.(1);Jiménez, I.(1);Erdozáin, I.(1);Rodríguez, P.(1);Fraga, A.(1);De Castro, L.(1);Oyón, D.(1);Huerta, A.(1);Carmona, M.(1);Esáin, A.(1);Cabriada, J.L.(1);Barreiro-de Acosta, M.(2);
Created: Friday, 14 July 2023, 11:12 AM
P849: Genetic variation within the NKG2D pathway may influence the response to anti-NKG2D therapy in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Hart1, E. Neiman1, J. Perrigoue1, L.-Y. Hao1, L. Tomsho1, W. Schultz1, A. Di Narzo2, K. Hao2, B. Skolnick3, T. Ort1, M. Curran1, S. Plevy1, M. Allez4*

Created: Thursday, 21 February 2019, 9:14 AM
P849: Urease-positive proteobacteria in Crohn’s disease identified by novel ex vivo mucosal microbe culture combined with metagenomic sequencing (MC-MGS): the ENIGMA study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. M. Berendsen*1,2, E. C. Hoedt1,2,3, J-J. Teh1,2, J. Zhang4,5, F. Zhang4,5, Q. Liu4,5, A. L. Hamilton6, J. Ching4,5, J. J. Sung4,5, J. Yu4,5, S. C. Ng4,5,7, M. A. Kamm6, M. Morrison1,2

Created: Friday, 22 February 2019, 9:41 AM
P850 Comparison of sampling methods in assessing the microbiome from patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H.S. Lee1, T.O. Kim2, S.H. Jung3, D.H. Baek4

Created: Thursday, 30 January 2020, 10:12 AM
P850: Co-medication before and after onset of inflammatory bowel disease in adults or elderly
Year: 2023
Source: ECCO’23 Copenhagen
Authors: LundPhD student, K.(1)*;Zegers, F.D.(2);Nielsen, J.(3);Brodersen, J.B.(4);Knudsen, T.(4);Kjeldsen, J.(5);Larsen, M.D.(6);Nørgård, B.M.(7);
Created: Friday, 14 July 2023, 11:12 AM
P850: Genetic variants of MGAT5 gene are associated with ulcerative colitis severity and response to therapy
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.S. Pereira1,2*, C. Durães1, T.A. Catarino1, I. Cleynen3, R. Marcos-Pinto2,4, J.C. Machado1,5, F. Magro6, S. Vermeire3, P. Lago4, S.S. Pinho1,5

Created: Thursday, 21 February 2019, 9:14 AM
P850: Measles virus immune status in a cohort of Spanish patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Gómez-Outomuro1, A. Castaño-García1, P. Flórez-Díez1, R. de Francisco*1,2, M. Rodriguez3, I. Huerta-González4, I. Pérez-Martínez1, S. Martínez-González1, M. Fernández-Prada5, A. Suárez1,2, S. Riestra1,2

Created: Friday, 22 February 2019, 9:41 AM
P851 Effects of conservation time on the diversity and relative abundance of intestinal microbiome in samples of faecal matters
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. León F1,2, C.A. Nieto2, Z. Corredor2, C. Flórez-Sarmiento3, V. Parra-Izquierdo3,4, C. Romero-Sanchez1,4

Created: Thursday, 30 January 2020, 10:12 AM
P851: Effects of manipulation of the gut microbiota on colon tumorigenesis in AOM-DSS model
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. S. Eun*1, D. S. Han1, J. G. Lee1, C. H. Park1

Created: Friday, 22 February 2019, 9:41 AM
P851: Impact of an integrated model of care for inflammatory bowel disease on direct healthcare costs: A population-based matched cohort study from Saskatchewan, Canada
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Maldonado, F.(1,2)*;Penz, E.(3);Jones, J.(4);Pena-Sanchez, J.N.(2);
Created: Friday, 14 July 2023, 11:12 AM
P851: Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Koeninger1*, N.S. Armbruster1, Z. Hu2, B. Jensen3, E.F. Stange1, P. Nordkild4, N.P. Malek1, L. Zender2, J. Wehkamp1

Created: Thursday, 21 February 2019, 9:14 AM
P852 Introduction of Entamoeba histolytica serology testing in the management of inflammatory bowel disease patients at University Hospitals of Leicester, UK
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. O’Meara1, Q. Tufail1, F. Lim2, C. Richards3, A.A. Thi1

Created: Thursday, 30 January 2020, 10:12 AM
P852: A metabolomics approach to discover biomarkers of chronic intestinal inflammation associated with gut microbiota dysbiosis in ulcerative colitis and Celiac Disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Sitkin1,2*, T. Vakhitov1, E. Tkachenko3, E. Avalueva2, L. Oreshko2, T. Zhigalova2, E. Demyanova1, O. Shalaeva1, V. Utsal4, M. Suvorova5, E. Komlichenko6

Created: Thursday, 21 February 2019, 9:14 AM
P852: Characterisation of Crohn’s disease mucosa-associated microbiota by a novel combination of microbe culture and metagenomic sequencing (MC-MGS): the ENIGMA study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. M. Berendsen*1,2, E. C. Hoedt1,2,3, J-J. Teh1,2, J. Zhang4,5, F. Zhang4,5, Q. Liu4,5, A. L. Hamilton6, A. Wilson-O'Brien6, J. Ching4,5, J. J. Sung4,5, J. Yu4,5, S. C. Ng4,5,7, M. A. Kamm6, M. Morrison1,2

Created: Friday, 22 February 2019, 9:41 AM